SCHEMBL2250853

SCHEMBL2250853

O=C(O)c1ccc(-c2ccc(F)cc2)cc1CCc1ccc(CCc2ccccc2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DCLRE1B Q9H816 2/20 0.54
DCLRE1A Q6PJP8 1/20 0.54
HCAR2 Q8TDS4 2/20 0.52
RARB P10826 2/20 0.49
RARA P10276 1/20 0.49
RARG P13631 1/20 0.49
BCL2L1 Q07817 1/20 0.47
BAD Q92934 1/20 0.47
ACLY P53396 1/20 0.46
ADRB3 P13945 2/20 0.46
ADRB1 P08588 1/20 0.46
MRGPRX4 Q96LA9 1/20 0.45
PLAAT3 P53816 1/20 0.45
PLAAT5 Q96KN8 1/20 0.45
PLAAT2 Q9NWW9 1/20 0.45
PLAAT4 Q9UL19 1/20 0.45
BRS3 P32247 1/20 0.45
PPARA Q07869 1/20 0.44
STING1 Q86WV6 1/20 0.44
HNF4A P41235 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2251799 0.97 DCLRE1B (0.57) DCLRE1BDCLRE1AHCAR2RARBRARA
SCHEMBL2254822 0.92 DCLRE1B (0.56) DCLRE1BDCLRE1AHCAR2BCL2L1BAD
SCHEMBL2253118 0.90 BCL2L1 (0.56) DCLRE1BDCLRE1AHCAR2RARBRARA
SCHEMBL2255248 0.88 SOX18 (0.50) DCLRE1BDCLRE1AHCAR2RARBRARA
SCHEMBL2258533 0.88 PTPN1 (0.50) DCLRE1BDCLRE1AHCAR2BCL2L1BAD
SCHEMBL2257940 0.85 ELOVL1 (0.49) DCLRE1BDCLRE1AADRB3
SCHEMBL2257377 0.84 ADRB3 (0.43) DCLRE1BDCLRE1AHCAR2RARBRARA
SCHEMBL2252452 0.83 BCL2L1 (0.46) DCLRE1BDCLRE1AHCAR2RARBRARA
SCHEMBL2258585 0.82 PTPN1 (0.47) DCLRE1BDCLRE1AHCAR2RARBRARA
SCHEMBL12062912 0.82 NR4A2 (0.46) BCL2L1BAD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1904047-B1 APOPTOSIS PROMOTERS ABBOTT LAB (US) 2013-01-02 EP disclosed
US-7989656-B2 Biaryl carboxylic acid apoptosis promoters ABBOTT LABORATORIES (US) 2011-08-02 US disclosed
US-20100234456-A1 APOPTOSIS PROMOTERS ABBOTT LABORATORIES (US) 2010-09-16 US disclosed
US-7750004-B2 Apoptosis promoters ABBOTT LABORATORIES (US) 2010-07-06 US disclosed
US-20070135392-A1 Apoptosis promoters ABBVIE INC. 2007-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100234456-A1 APOPTOSIS PROMOTERS MCL1, BAX, BCL2 DCLRE1B 129/4885DCLRE1A 270/4885HCAR2 4597/4885
US-20070135392-A1 Apoptosis promoters MCL1, BAX, BCL2 DCLRE1B 129/4885DCLRE1A 270/4885HCAR2 4597/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.